102 filings
Page 4 of 6
6-K
ut2 vv60rmhi6o5xjdjl
5 May 22
Opthea Data for OPT-302 in Combination with Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) Presented at ARVO 2022
6:02am
6-K
kpbimfa
29 Apr 22
Opthea Presenting Clinical Data at ARVO 2022 Annual Meeting
6:03am
6-K
bw9nb5zddj6oey7sn
22 Apr 22
Current report (foreign)
7:01am
6-K
el7l23n3t9n3q1l5hww
22 Apr 22
Current report (foreign)
7:00am
6-K
smmq0o
22 Apr 22
Current report (foreign)
6:02am
6-K
4dy8l7p ao1cl1eqws
30 Mar 22
Index to Condensed Consolidated Financial Statements
5:18pm
6-K
ysqn4jootx
10 Mar 22
Opthea To Present at Oppenheimer’s 32nd Annual Healthcare Conference
4:15pm
6-K
7aq6yqb9fsnry465
2 Mar 22
Current report (foreign)
4:16pm
6-K
cwyxzx4qg1k
28 Feb 22
Current report (foreign)
6:10am
6-K
rcrecxtec06wr
14 Feb 22
Current report (foreign)
6:41am
6-K
5jdvdplt6r7cexd3d61m
10 Feb 22
Opthea To Present at SVB Leerink Global Healthcare Conference
4:01pm
6-K
ltm5zx581cg5q3vb
9 Feb 22
Opthea Announces Presentation at the Angiogenesis, Exudation, and Degeneration 2022 Conference
5:16pm
6-K
zumgvn
1 Feb 22
Opthea Announces Establishment of At-The-Market Equity Program
6:46am
6-K
ig7nt2ntj7qkctj
24 Jan 22
Current report (foreign)
4:10pm
6-K
kaf6h18
4 Jan 22
Opthea To Present at H.C. Wainwright BIOCONNECT Virtual Conference
4:54pm
6-K
typk6 0ftvi
3 Jan 22
Current report (foreign)
4:11pm
6-K
eyalsjxvjt4
26 Oct 21
Opthea Granted Chinese Patent Covering OPT-302
5:14pm
6-K
mtblfw
20 Oct 21
Current report (foreign)
12:00am
6-K
o08 asj64bp6eoeh
4 Oct 21
Current report (foreign)
4:16pm
6-K
bs8e86ti49vjpef
20 Sep 21
Additional Agm Resolution & Addendum to the Notice of Annual General Meeting and Explanatory Notes
5:01pm